Hemoglobin types of Macaca irus and Macaca mulatta monkeys

Hemoglobin of 30 Macaca mulatta monkeys and of 15 Macaca irus monkeys consisted of one electrophoretic component similar to human hemoglobin A. Twenty-one M. irus monkeys had two types of hemoglobin. In 20 animals the hemoglobin resembled human hemoglobin AJ, and in one animal it resembled human hemoglobin AI.     

Kikuyu poisoning of cattle in New South Wales and its relationship to pasture fungi on kikuyu grass (Pennisetum clandestinum)

In the late summer and autumn of 1980 kikuyu poisoning of cattle was diagnosed on 9 farms in New South Wales resulting in 213 deaths among 1370 cattle at risk. Clinical, autopsy and histopathological findings are described and are consistent with those previously recorded. Kikuyu grass samples from 5 paddocks in which deaths were occurring were examined for the presence of fungi. Myrothecium spp were not present. Fusarium semitectum, F. moniliforme var subglutinans, Penicillium spp and a Phoma sp were the most common fungi isolated but with the exception of F. semitectum were not consistently present. F. semitectum was present in adjacent kikuyu grass paddocks in which deaths were not occurring. Two of the farms had army caterpillar (Mythimna convecta) infestations. Army caterpillar faeces present in these paddocks did not contain Myrothecium spp; the fungi present reflected the population present on the kikuyu grass. These findings do not suggest a mycotic cause for kikuyu poisoning.     

Depletion of gentamicin in the milk of Holstein cows after single and repeated intramammary and parenteral treatments

Twenty-four healthy Holstein cows, 2.72 ± 0.64 (mean ± SD) years old, weighing 603.96 ± 73.22 kg (mean ± SD), and representing various levels of milk production, were used to determine the depletion of gentamicin (GT) in milk. The cows had not received antibiotics or other drugs that could interfere with study for at least 60 days before the beginning of the investigation. The cows were divided into six groups (n = 4) and treated with single (treatments A, B and C) or repeated (treatments D, E and F) doses of GT. Cows were acclimated for 7 days before administration of GT and milked twice a day at 12-h intervals (06.00 hours, 18.00 hours) throughout the duration of the study. Control milk samples were obtained after the arrival of the cows and assayed to establish their GT free status. On day 1 of each treatment, a baseline milk sample was collected from the milk produced (06.00 hours) by each cow. A single dose of GT was administered intramammarlly (A, i.m.m. left front quarter, 500 mg), intravenously (B, i.v., 5 mg/kg body weight) or intramuscularly (C, i.m., 5 mg/kg body weight). Cows in treatments D (i.m.m., 500 mg), E (i.v., 5 mg/kg body weight) and F (simultaneous i.m.m. 500 mg plus i.v. 5 mg/kg body weight) were treated twice a day for 5 consecutive days just after the morning and evening milkings. Milk samples from individual cows were collected every day after each milking during and after dosing until GT concentration in the milk was below the safe level of ± 30 ng/mL. The concentration of GT in milk was determined by a high-performance liquid chromatographic procedure. Depletion of GT to a concentration ± 30 ng/mL occurred at the seventh (84 h), third (36 h), third (36 h), eleventh (132 h), third (36 h) and nineteenth (228 h) post-dosing milking, for cows in treatments A, B, C., D, E and F respectively. The highest mean ± SEM) concentrations of GT were 14 710 ± 1213.89, 167.87 ± 46.94 and 91.62 ± 14.55 ng/mL measured in the first milking post dosing (12 h) for cows in treatment A, B and C respectively; for cows in treatments D, E and F, during the dosing period, they were 14067.50 ± 2989.09, 446.07 ± 100.92, and 22900 ± 2843.66 ng/mL and occurred at the seventh, third and eighth milking respectively. Because GT is not approved for use in dairy cattle and because of the long depletion time associated with some possible treatments, illegal and extra-label use is likely to cause residues in milk.     

Suppression of testicular function using two dose rates of a reversible water soluble gonadotrophin releasing hormone (GnRH) vaccine in colts

Objective: To investigate the effect of two dose rates (200 and 400 ng) of a gonadotrophin releasing hormone (GnRH) vaccine on testicular function. Design: A vaccination dose rate experiment. Procedure: Two injections were administered 4 weeks apart to six colts in each treatment group. To maintain immunosuppression until the end of the breeding season, a third injection was given if antibody titres fell below 1000. Results: Effective antibody titres were present for 12 to 27 weeks. Testosterone concentrations decreased from 2.22 to 0.31 nmol/L 6 weeks after primary vaccination. Androstenedione concentrations decreased from 1.78 to 0.28 nmol/L 5 weeks after vaccination. Testosterone and androstenedione concentrations above 0.69 and 0.87 nmol/L were attained 31 to 43 weeks after vaccination. Mean scrotal widths and lengths decreased over 29 weeks from 9.2 cm and 9.7 cm to 6.7 cm and 7.6 cm. At surgical castration these dimensions were 10.1 cm and 11.0 cm. Mean semen characteristics before vaccination and after recovery were: gel-free volume 16.5 and 13.5 mL, sperm concentration 295.5 times 10⁶ 315.6 times 10⁶/mL, total sperm per ejaculate 4041 times 10⁶ 4657 times 10⁶ live normal spermatozoa 32% and 60%. Histologically, the testes showed active spermatogenesis. The mean testicular parenchyma weights for the 200 and 400 mg groups were 129.0 g and 109.8 g. Daily sperm production per testis and per gram of testis for the 200 and 400 mg groups were 3.7 times 10⁸ 2.8 times 10⁶ 2.3 times 10⁸ 2.0 times 10⁶. Conclusions: Both dose rates suppressed testicular function. Data showed that the vaccine effects were reversible. Individual immune response was less varied in the 200 mg group. Further work is necessary to achieve a less variable response in the immunosuppression of testicular function.     

An Alternative to Aggregated Base Tables in Input-Output Table Regionalization

Analysts faced with the challenge of constructing a regional input-output table from partial or nonsurvey-based data typically adapt a national input-output table to reflect the regional economic structure. Detailed benchmark input-output tables with more than 500 industry sectors are compiled for years at five-year intervals, but are many years out of date by the time they are released. Annual updates are compiled for intervening years, but detail only 85 industry sectors. Analysts therefore must choose between the currency of the data and its detail in the national table that serves as the reference. This paper presents a table disaggregation and adjustment (TDA) method for combining the information from the detailed benchmark tables with the more current but aggregated data. Empirical tests demonstrate that the TDA method generates base data that analytically outperform the aggregated annual update data.     

Vanilla viruses in the South Pacific

Surveys for viruses affecting Vanilla fragrans and V. tahitensis carried out in Cook Islands, Fiji, Niue, Tonga and Vanuatu detected cymbidium mosaic potexvirus and odontoglossum ringspot tobamovirus in all countries; vanilla necrosis potyvirus in Fiji, Tonga and Vanuatu; and vanilla mosaic potyvirus in Cook Islands, Fiji and Vanuatu. For all these viruses the surveys extended the previously known distribution in the South Pacific. Other, unreported potyviruses and rhabdovirus-like particles were detected from Fiji and Vanuatu. Symptoms associated with potyvirus infection (leaf distortion, sunken chlorotic patches, stem necrosis and vine die-back) were found in a majority of plantings in Fiji, Tonga and Vanuatu; in Fiji and Tonga there were instances where up to 50% of the plants in farmers' plots were affected.